Perbedaan Organon Pharma Indonesia Tbk. dan Bersama Zatta Jaya Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Bersama Zatta Jaya Tbk. diperdagangkan di Rp67 (kapitalisasi pasar 586,22 M, volume 24 jam 51,53 jt). Perbedaan utamanya: Bersama Zatta Jaya Tbk. jauh lebih besar — sekitar 5,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | ZATA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 586,22 M |
Volume | — | 51,53 jt |
Lot | — | 515,28 rb |
Perputaran | — | 3,45 M |
Harga Rata-rata | — | 67,05 |
Nilai Transaksi | — | 3,45 M |
Harga Ekuilibrium Indikatif | — | 67 |
Volume Ekuilibrium Indikatif | — | 9,49 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Bersama Zatta Jaya Tbk (the Company) was established based on notarial deed No. 39 datedApril 16, 2012 of Ermilla Ananta Cahyani,S.H., notary in Bandung. The company started its commercial activities since 2012.
Selengkapnya di halaman ZATA →